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Background: Antimicrobial resistance is a major public health problem. Bacterial 
pathogens are increasingly exhibiting resistance to the commonly used antibiotics. 
During the last two decades ESBL producing Gram negative bacilli have emerged as 
a major problem in many settings. Timely and accurate reporting of microbiology 
susceptibility test results allows selection of more appropriate and focused therapy . 
Methods: A prospective cross sectional study was carried out which included all the 
gram negative bacilli isolated from various clinical specimen received in 
microbiology department. Growth was identified by conventional method. Total 290 
Gram negative aerobic isolates were identified. The antimicrobial susceptibility 
testing of all the Gram negative isolates was done using disc diffusion method. All 
the gram Negative bacilli  were screened for ESBL production and metallo Beta 
lactamase production by disc placement method . 
Results:  Out of the 290 strains isolated ,maximum isolates were of Klebsiella 
(40.34%), followed by E.coli (31.72%), 30-40% of isolated strains were multi drug 
resistant, 229 (78.96%) were ESBL producers. All the strains (100%) of Non 
fermenters,Acinetobacter and Burkholderia from indoor patients were ESBL 
producers followed by Klebsiella (96.03%),E.coli (95.58%) and Pseudomonas 
(86.04%). 
Conclusion: This study will help the Infection control committee in formulating 
antibiotic policy l. The data generated through this surveillance can guide the 
physician for appropriate therapy. ESBL detection should be routinely undertaken, to 
avoid misuse of beta-lactam antibiotics.The data of resistance strains within the 
hospitals should be generated not only at the local level but should be done at national 
level, so that region specific guidelines and policies on antibiotic prescription and 
usage may be formulated. 
  
 
INTRODUCTION 
Antimicrobial resistance is an issue of great significance for public health at the global level. Antibiotics which 
are considered as wonder drugs are often prescribed inappropriately and inadequately. Bacterial pathogens 
causing acute infections are increasingly exhibiting resistance to the commonly used antibiotics and have 
become a great threat to public health. The increasing antibiotic resistance problems in hospitals and community 
is a cause of great concern.1  
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 Compared to infections caused by drug susceptible gram negative bacteria infections caused by Gram 
negative bacteria are associated with higher morbidity and mortality particularly if inappropriate empiric al 
antibiotic therapy is prescribed.2 
 Hospital antibiograms can be a useful means for guiding empiric therapy and tracking the emergence 
of bacterial resistance among nosocomial isolates.1 
   Antimicrobial resistance is a growing threat worldwide. Resistance mechanisms have been 
found for every class of antibiotic agents. During the last 2 decades, extended-spectrum β-lactamases (ESBLs) 
found in gram-negative bacilli have emerged as a significant mechanism of resistance to oxyimino-
cephalosporin antibiotics. 3  
 With the spread of ESBL producing Gram negative bacilli in hospitals all over the world, it is 
necessary to know the prevalence of ESBL producing Gram negative bacilli in a hospital so as to formulate an 
antibiotic policy in high risk units where infections due to resistant organisms is higher.4 
Institution-specific data, such as susceptibility patterns and local antibiotic use need to be studied. 
Tailoring antimicrobial therapy based upon culture and sensitivity results wherever available will help reduce 
cost, decrease the incidence of super-infections, and minimize the emergence of resistance & mortality. 5  
 First described in 1980’s in Europe Extendeded spectrum beta latctam producing Enterobacteriaciae have 
emerged as serious nosocomial pathogens.6 
 Clinical laboratories play a vital role in providing accurate information and guidance in the treatment 
of microbial infection.7 Antimicrobial resistance among enteric gram negative bacteria is fast becoming a global 
public health concern with rapid increase in multi drug resistant organisms.8,1 
 The prevention of nosocomial infections and their transmission requires reliable microbiological 
diagnosis, rational antibiotic prescribing and effective infection control. The most important determinants in 
treating patients with infections in the ICU is prompt initiation of effective empiric therapy .9 
 All over world epidemics due to resistant Gram negative bacilli are increasing rapidly.World Health 
Day 2011 theme was “Antimicrobial Resistance;no action today,no cure tomorrow”. 10  
MDR:  Multi drug resistance among gram negative bacteria  was defined as  resistance to three or more of the 
following antibiotics Ceftazidime, Ciprofloxacin, Meropenem, Gentamicin, Ampicillin/sulbatam, or 
Piperacillin/tazobacam. These antimicrobials were chosen because they are commonly prescribed by 
physicians.11 
Considering all these facts this study was planned to carry out the surveillance of antibiotic resistance 
in a tertiary care hospital . 
AIMS & OBJECTIVES 
     1. To isolate gram negative bacilli from various clinical specimen.     
     2. To carry out antibiotic sensitivity of all isolates.   
     3. To know the frequency of multidrug resistant Gram Negative Bacilli. 
 
MATERIAL & METHODS 
Study design : Prospective cross sectional study 
Sample size  :  All the gram negative bacilli isolated from various clinical specimen received in microbiology 
department of a tertiary care hospital for a duration of 3 months. 
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All the samples received in Microbiology Lab were inoculated on Blood Agar and MacConkey Agar. These 
plates were incubated aerobically at 370c for 24 hrs . Growth was identified by conventional method.12 Total 
290 Gram negative aerobic isolates were identified from various clinical specimen (IPD &OPD). 
The antimicrobial susceptibility testing of all the Gram negative isolates was done using disc diffusion 
method.13 Test organisms were suspended in normal saline to 0.5 McFarland standard and then inoculated on 
Muller Hinton agar plates followed by overnight incubation at 370c for 18-24 hrs. For urinary isolates the 
antibiotic sensitivity was tested against Amoxycillin+Clavulanic acid,Norfloxacin, Ciprofloxacin, 
Nitrofurantoin,Cotrimoxazole,Ceftriaxone and Ceftazidime disk.For isolates which were obtained from other 
samples the antibiotic disks used were Gentamicin, Amoxycillin+Clavulanic acid,  Ciprofloxacin, Cefuroxime, 
Ceftriaxone &Ceftazidime disk. 
For Pseudomonas and acinetobacter species Imipenem, Ciprofloxacin, Gentamicin, piperacillin, Ceftriaxone & 
Ceftazidime disk were used. 
ATCC E.coli 25922and ATCC Psedomonas aeruginosa 27853 were used as control strains for quality control of 
disk diffusion test.  Interpretation was done using guidelines laid down in the CLSI manual, which provides 
break points corresponding to zone of inhibition diameter.13 
All the gram Negative bacilli  were screened for ESBL production and metallo Beta lactamase production by 
disc placement method described by Camella Rodrigues.The lawn culture of test organism was made on Muller 
–Hinton Agar as done for disk diffusion antimicrobial susceptibility test in the centre of the plate, Imipenem 
(10ug)disk was applied. At the distance of 20 mm, the disc of cefotaxime (30ug)was placed . 
From this disk, in a circular manner, clockwise, the disk of  Cefoxitin (30ug), 
ceftriaxone(30ug),ceftazidime930ug),ceftazidime+clavulanic acid(30+10ug)  and Aztreonam (30ug) were 
placed such that any two adjacent discs were 20 mm apart from centre to centre. On overnight aerobic 
incubation at 370 c the diameter of zones of inhibition were measured and interpreted as follows 14 :  
ESBL 
1)Zone diameter for aztronam <27mm,cefotaxime<27mm, ceftazidime < 22mm,   
    ceftriaxone < 25mm.  
2) Susceptible to cefoxitin 
3) Increase in zone size with addition of inhibitor (ceftazidime+cavulanic acid) by   
     5mm or more. 
Metallo Beta lactamases were identified as Strains showing resistance to Imipenem. 
OBSERVATIONS & RESULTS 
Total 290 strains were isolated from various clinical specimen during a period of three months. The distribution 
of specimen was as follows .  
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Table I    Distribution  of specimen n=290 
Sample IPD OPD TOTAL 
 
Urine 85 17 102 
Pus 55 13 68 
Sputum 33 8 41 
Pleural fluid 33 00 33 
ET Secretions  28 00 28 
Blood 12 00 12 
Ascitic Fluid 6 00 6 
 
Total 
 
252 
 
38 
 
290 
 
 As seen from Table I Out of the 290 strains isolated maximum isolates (102) were from Urine samples 
followed by  pus  and Sputum.   
Table II Frequency of Gram Negative Bacilli among clinical specimen n=290 
Organism                                                            Specimen 
 Urine Pus Sputum Pleural 
fluid 
E.T. 
Secretions 
Blood  Ascitic  
Fluid 
Total (%) 
Klebsiella 26 15 28 29 19 00 00 117(40.34%) 
E.coli 56 20 00 00 00 10 06 92(31.72) 
Pseudomonas 16 32 05 00 05 00 00 58(20%) 
Non fermentor 02 01 04 02 02 02 00 13(4.48%) 
Acinetobacter 00 00 02 02 02 00 00 06(2.06) 
Burkholderia 00 00 02 00 00 00 00 02(0.68%) 
Proteus 02 00 00 00 00 00 00 02(0.68%) 
 
Table II shows the distribution of Gram negative bacilli among the clinical specimen. Out of 290 organisms 
maximum isolates were of Klebsiella (40.34%), followed by E.coli (31.72%), Pseudomoas (20%). Whereas few 
strains of Non fermenters (4.48%), Acinetobacter(2.06%),Burkholderia(o.68%) and Proteus (0.68%) were 
isolated in this study. 
                                       Table III  Distribution of organisms in Indoor patients n=252 
Organism In patient 
Klebsiella 102(40.47%) 
E.coli 81(32.14%) 
Pseudomonas 48(19.04%) 
NonFermenter 13(5.15%) 
Acinetobacter 06(2.38%) 
Burkholderia 02(0.79%) 
Proteus 00(00%) 
Total 252 
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As seen from Table III out of the 252 strains isolated from Indoor patients maximum strains were of 
Klebsiella(40.47%) and E. Coli (32.14%). 
 Table IV  Distribution of organisms in Outdoor patients n=38 
Organism Out Patient 
Klebsiella 15(39.47%) 
E.coli 11(28.94%) 
Pseudomonas 10(26.31%) 
NonFermenter 00(00%) 
Acinetobacter 00(00%) 
Burkholderia 00(00%) 
Proteus 02(100%) 
Total 38(13.10%) 
 
From Table IV it is evident that both the proteus strains isolated during this study were from outdoor patients. 
Table V Antibiotic resistance pattern of Gram Negative bacilli isolated from Urine  n=102 
Antibiotic No.Sensitive(%) No.Resistant (%) 
Amoxycillin+Clavulanic acid 28 ( 27.45  %) 74 (72.54%) 
Norfloxacin 69(67.64%) 33 (32.35%) 
Ciprofloxacin 78(76.47%) 24 (23.52%) 
Nitrofurantoin 89 (87.25%) 13 (12.74%) 
Cotrimoxazole 72 (70.58%) 30 (29.41%) 
Ceftriaxone 68 (66.66%) 34(33.33%) 
Ceftazidime 72 (70.58%) 30 (29.41%) 
  
Table V shows the antibiotic sensitivity pattern of Gram negative bacilli from Urine samples. Out of 102 strains 
72.54% were resistant to Amoxycillin +clavulanic acid.Almost 30% strains are resistant to 
Norfloxacin,cotrimoxazole,ceftriaxone and ceftazidime. Wereas only 12.74% strains were resistant to 
Nitrofurantoin. 
TableVI  Antibiotic Resistance pattern of Gram Negative bacilli isolated from specimen other than urine 
n=124 
Antibiotic No.Sensitive (%) No.Resistant (%) 
Amoxycillin+Clavulanic acid 33( 26.61%) 91 (73.38%) 
Gentamicin 97 (78.22%) 27 (21.77%) 
Ciprofloxacin 85 (68.54%) 39 (31.45%) 
Cefuroxime 69 (55.64%) 55 (44.35%) 
Ceftriaxone 71 (57.25%) 53 (42.74%) 
Ceftazidime 68 (54.83%) 56 (45.16%) 
 
Out of 124 strains from samples other than urine ,73.38% strains were resistant to Amoxy+Clavulanic 
acid,about 40%strains were resistant to Cefuroxime and 3rd generation cephalosporins,while resistance to 
ciprofloxacin was noted in 31.45% and to Gentamicin in 21.77%. 
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Table VII Antibiotic resistance pattern of Pseudomonas & Acinetobacter isolated . n=64 
Antibiotic No.Sensitive(%) No.Resistant(%) 
Imipenem 60 (93.75%) 04 (6.25%) 
Ciprofloxacin 38 (59.37%) 26 (40.62%) 
Gentamicin 50 (78.12%) 14 (21.87%) 
Piperacillin 31 (48.43%) 33 (51.56%) 
Ceftriaxone 41 (64.06%) 23 (35.93%) 
Ceftazidime 52 (81.25%) 12 (18.75%) 
  
Table VII shows that in this study the Pseudomonas and Acinetobacter species were resistant to Imipenem in 
only 6.25% strains, followed by Ceftazidime 
(18.75%),Gentamicin(21.87%),Ceftriaxone(35.93%),Ciprofloxacin(40.62%)and Piperacillin(51.56%). 
From the Tables V,VI,VII it is evedent that almost 30-40% strains are multi drug resistant. 
Table VIII  ESBL producing Gram Negative Bacilli 
Organism Number isolated Number of ESBL Producers 
(%) 
Klebsiella 117 101(86.32%) 
E.coli 92 68(73.91%) 
Pseudomonas 58 43(74.13%) 
NonFermenter 13 09(69.23% 
Acinetobacter 06 06(100%) 
Burkholderia 02 02(100%) 
Proteus 02 00(00%) 
Total 290 229(78.96%) 
  
All the gram negative isolates in this study were tested for ESBL production. Table VIII shows that out of 290 
Gram negative bacilli isolated 229 (78.96%) were ESBL producers. All the strains of Acinetobacter and 
Burkholderia were ESBL producer whereas no strain of proteus showed ESBL production. Maximum ESBL 
production was observed in Klebsiella (86.32%), followed by Pseudomonas (74.13%), E.coli (73.91%) and 
Nonfermenters (69.23%). 
Table  IX  Distribution of ESBL producing isolates from  Indoor &Outdoor patients n=229 
Organism In patient Out Patient Total 
Klebsiella 97(96.03%) 04(3.96%) 101 
E.coli 65(95.58%) 03(4.41%) 68 
Pseudomonas 37(86.04%) 06(13.95%) 43 
NonFermenter 09(100%) 00(00%) 09 
Acinetobacter 06(100%) 00(00%) 06 
Burkholderia 02(100%) 00(00%) 02 
Proteus 00 00 00 
Total 216(94.32%) 13(5.67%) 229 
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From Table IX it is evident that out of 229 ESBL producing Gram negative bacilli 216(94.32%)  strains were 
isolated from indoor patients and only 13(5.67%) from outdoor patients. All the strains (100%) of Non 
fermenters,Acinetobacter and Burkholderia from indoor patients were ESBL producers followed by Klebsiella 
(96.03%),E.coli (95.58%) and Pseudomonas (86.04%). 
DISCUSSION 
Cephalosporins are widely used as drug of choice for Gram negative infections. Their inappropriate use leads to 
development of drug resistance. The hospital strains are becoming multi drug resistant in many health care 
setups. Most of the Gram negative isolates from critical areas are ESBL producers .  
 This study was planned to know the frequency of multidrug resistant Gram negative bacilli. Total 290 
strains of Gram negative bacilli were isolated from various clinical specimen. Maximum isolates (102) were 
from Urine samples followed by 68 from pus samples, 41 from Sputum. 33 Gram negative strains were isolated 
from pleural fluid and 28 from ET Secretions. Whereas only 12 strains were isolated from blood culture and 6 
from ascitic  fluid. 
In a study carried out by Kalidas Rit et al in 2013 highest number of non fermenters were from Pus specimen. 
Clinical conditions associated with non fermenting Gram negative bacilli were Surgical site infections, 
Ventilator associated pneumonia, urinary tract infection and septicaemia. Pseudomonas and acinetobacter were 
more commonly isolated from SSI and UTI.15  
In the present study it was observed that maximum isolates were of Klebsiella (40.34%),followed by E.coli 
(31.72%),Pseudomonas (20%). Whereas few strains of Non 
fermenters(4.48%),Acinetobacter(2.06%),Burkholderia(o.68%) and Proteus (0.68%) were isolated in this study. 
In a study conducted by Stephen E Mshana et al in Tanzania in 2009 E.coli was the commonest organism 
isolated from urine specimen and Acinetobacter from infected wounds.9 In another study also E. Coli was 
isolated from maximum samples followed by Klebsiella.7  
 Deep Gagneja et al  reported that from Lower respiratory tract infections (LRTI) commonest organism 
was Pseudomonas (30-50%) followed by Klebsiella but from 2005-2006 onwards ,the rate of isolation of 
Acinetobacter species increased from 11.8%(2004-2005) to 25% (2008-2009).16  
 Jethawani in 2014 reported that most common isolates in their study were  Acinetobacter spp. (31.25%) 
followed by Klebsiella spp.(21.87%), E-coli (21.87%) and Pseudomonas Spp. (17.7%).17 
 From our study it is evident that most of the Gram negative bacilli isolated were resistant to 
Amoxy+clavulanic acid, Gentamicin and 3rd generation cephalosporins (more than 30 %) indicating multi drug 
resistance. 
RUBEENA HAFEEZ ET AL 2009 reported 100% susceptibility to Imipenem for all the isolates and to Amikacin 
(85%).7   Whereas in another study most of the Gram negative bacilli were resistant to Ampicillin and 43.5 % of 
isolates were resistant to 3rd Generation cephalosporins.9 
In a study conducted by Jethwani for aminoglycosides, strains were equally sensitive to amikacin, gentamicin 
and tobramycin (47%). Among fluoroquinolones, strains were equally sensitive to ciprofloxacin, levofloxacin 
and gatifloxacin (24%). All the strains of E.coli were sensitive to carbapenems, colistin, polymyxin B  and 
sensitivity to 3rd generation cephalosporins-cefotaxime, ceftriaxone and ceftazidime was 22%. All Strains of 
Klebsiella  were resistant to 3rd generation cephalosporins. Sensitivity to piperacillin-tazobactam was 33%.17 
 
 Satyajeet K.Pawar et al reported 19.1% sensitivity to Aminoglycosides and 62.2% of total isolates were 
multidrug resistant. Less susceptibility to cephalosporins might be due to ESBL producing strains while over 
use of quinolones and penicillin group may be responsible for resistance against these group.10  
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In a study from Chandigarh in 2003 a total of 42% strains of Pseudomonas aeruginosa were found to be resistant 
to Imipenem.18 
Study by Van Eldere showed that amikacin among aminoglycosides and ciprofloxacin among fluoroquinolones 
were the potent antibiotics against Pseudomonas spp.19   Similarly in Banglore,Pseudomonas showed 60-70% 
resistance to Amikacin, ceftazidime and ciprofloxacin. 20  
 Erdem et al reported 59% P. aeruginosa isolates resistant to ceftazidime, 32% to imipenem, and 62% 
to ciprofloxacin. 21,19  while in another study Pseudomonas isolates were highly susceptible to colistin, 
Imipenem, Amikacin and Cefaperazone/sulbactum combination.15 
 Pathmanathan et al in 2009 showed 77.3% and 79.4% of  Pseudomonas isolates were susceptible to meropenem 
and imipenem respectively.22  
 In 2014 Jethwani reported that 5 (24%) isolates were resistant to carbapenems . Antipseudomonal 
agents- piperacillin, ceftazidime and piperacillin-tazobactam had 29%, 41% and 35% sensitivity respectively. 17 
  In our study the Pseudomonas and Acinetobacter species were resistant to Imipenem in only 6.25% strains, 
followed by Ceftazidime (18.75%), Gentamicin (21.87%) , Ceftriaxone (35.93%), Ciprofloxacin(40.62%)and  
Piperacillin(51.56%). 
The antibiotic susceptibility pattern may change with time and may vary from hospital to hospital. Beta 
lactamase enzymes produced by Gram negative organisms confer resistance to broad spectrum beta lactam 
antibiotics. 
Studies on ESBL production among enterobacteriaceae isolated from clinical specimen showed a variable 
incidence ranging from 1% to 74%.23,24 
In our study out of 290 Gram negative bacilli isolated 229(78.96%) were ESBL producers. All the strains of 
Acinetobacter and Bueholderia were ESBL producers whereas no strain of proteus showed ESBL production. 
Maximum ESBL production was observed in Klebsiella (86.32%),followed by Pseudomonas (74.13%),E.coli 
(73.91%)and Nonfermenters (69.23%). 
In India  prevalence of ESBL production varies from 10%-84% 25. In a study done by Nathisuwan S in 2001 
ESBL were more prevalent in Klebsiella followed by E.coli.26  A study from North India on Uropathogens 
showed that 26.6 % of the isolates were ESBL producers whereas a study from Nagpur showed that 48.3% of 
cefotaxime resistant Gram negative bacilli were ESBL producers. 27 
Babypadmini S carried out the study in tertiary care hospital in 2004 and observed that  41% E.coli and 40% 
Klebsiella showed ESBL production.28 
In a similar study by Mathur et al 62% of the E.coli and 73% of the Klebsiella isolates were reported to be 
ESBL producers.29 Predominant prevalence of ESBL among E.coli isolates was also reported by 
Ananthakrishnan et al.25 and Kumar et al.30 
In a study done by RUBEENA HAFEEZ ET AL prevalence of ESBL production in Gram Negative isolate was found 
to be 35.5% in which prevalence of 44.8% and 38.6% was found for E.coli and Klebsiella respectively.7 
ESBL production was 81% in E.coli and 74% in Klebsiella in a study done by UMADEVI S.31 
 In Indian hospitals ESBL producing Klebsiella species were predominant organisms responsible for high 
morbidity.5 Recent studies on ESBL production among the members of Enterobacteriaceae which were isolated 
from clinical specimens showed an increase in the occurrence of ESBL producers.  32  
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In one study Gram negative isolates showing resistance to 3rd generation cephalosporins were tested for ESBL 
production and ESBL prevalence was found to be 98.51% .33 
 50%  E- coli and 38% of  Klebsiella pneumonia strains were ESBL producers in a study done by Jethwani.17  
 
The occurance of Multi drug resistant organisms not only limits the therapeutic options but also poses a 
challenge for Microbiology labs to identify them. 
In our study resistance to Imipenem was noted in only 6.25% strains of Psedomonas. Gladstone P while 
evaluating respiratory isolates also found lower resistance of 12.2 % to carbapenems in non fermenters.34 
 High prevalence of resistance to Imipenem in E.coli,Klebsiella, Pseudomonas, Acinetobacter in wards 
and ICU as 2&13%, 31&51%, 39&59%, 57&80% respectively by Chand Wattal et al in 2010.5 
The clinical microbiology laboratory is a key component in the function of antimicrobial stewardship 
programme. Timely and accurate reporting of microbial susceptibility test results allows selection of more 
appropriate and focused therapy and may help reduce broad spectrum antimicrobial use. 
CONCLUSION  
The data generated through surveillance of antibiotic resistance in Gram Negative bacilli, can provide an in 
depth knowledge regarding impending treatment failures and guides the physician for appropriate therapy. 
ESBL detection and its drug susceptibility pattern should be routinely undertaken, to avoid overuse or misuse of 
beta-lactam antibiotics in clinical practice. 
In this study it was observed that about 30-40% strains were multi drug resistant and ESBL production was seen 
in 78.96% gram negative bacilli. This study will help the Infection control committee in formulating antibiotic 
policy for our hospital. 
This data will help the infection control committee in formulating the antibiotic policy for our hospital which is 
a backbone of Antibiotic stewardship programme. 
Antibiotic susceptibility data generated by the microbiology laboratories should be shared with the clinicians. 
The data of resistance strains within the hospitals should be generated not only at the local level but should be 
done at national level, so that region specific guidelines and policies on antibiotic prescription and usage may be 
formulated.  
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